(ESPR)
Esperion Therapeutics Inc (ESPR) volume exceeds 7.01 million: A new investment opportunity for investors
Esperion Therapeutics Inc (NASDAQ: ESPR) on Monday, plunged -7.23% from the previous trading day, before settling in for the closing ...
Esperion Therapeutics Inc (ESPR) posted a 30.39% change over the last five days signaling a new trend
Esperion Therapeutics Inc (NASDAQ: ESPR) kicked off on Tuesday, up 16.40% from the previous trading day, before settling in for ...
Esperion Therapeutics Inc (ESPR) last month volatility was 7.20%: Don’t Ignore this Blaring Warning Signal
Witnessing the stock’s movement on the chart, on Thursday, Esperion Therapeutics Inc (NASDAQ: ESPR) set off with pace as it ...
44.17% percent quarterly performance for Esperion Therapeutics Inc (ESPR) is not indicative of the underlying story
Esperion Therapeutics Inc (NASDAQ: ESPR) on Friday, soared 6.40% from the previous trading day, before settling in for the closing ...
Esperion Therapeutics Inc (ESPR) with a beta value of 1.04 appears to be a promising investment opportunity.
Esperion Therapeutics Inc (NASDAQ: ESPR) on Tuesday, plunged -3.39% from the previous trading day, before settling in for the closing ...
A major move is in the offing as Esperion Therapeutics Inc (ESPR) market cap hits 671.71 million
On Monday, Esperion Therapeutics Inc (NASDAQ: ESPR) opened higher 7.01% from the last session, before settling in for the closing ...
Esperion Therapeutics Inc (ESPR)’s latest performance is not what we had anticipated
A new trading day began on Friday, with Esperion Therapeutics Inc (NASDAQ: ESPR) stock price up 13.79% from the previous ...
